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In Vitro Models and Methods for
Bioassay and Studies of
Cellular Mechanisms*
Relationship Between In Vivo and
In Vitro Testing
This report discusses the use ofin vitro systems
to detect metal carcinogens and to provide inforna-
tion on the mechanisms of metal carcinogenesis.
The use ofin vivo systems is also discussed, where
they may provide additional information. Even
though no single system has proven adequate for
the definitive identification of all metal mutagens
and carcinogens, the aggregate results of these
studies indicate that the combined use of several
systems may provide a valuable, initial screen for
metals and their compounds. It is now imperative
to evaluate more complex aggregates and mixtures
of metals and their compounds that are environ-
mentally ubiquitous (1). Metals appear to behave
similarly to othercarcinogens in celltransformation
tests; however, they are frequently negative in
bacterial mutagenesis revertant assays.
In addition to rapid screening, cellular systems
are particularly advantageous for analyzing the
mechanismofmetalmutagenesisandcarcinogenesis.
It is only in such systems that one may be able to
study the mechanism and specificity of metal-
induced cellular alterations which may be causative
factors in neoplasia. The physiological chemistry of
different metals may vary widely. For example,
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arsenic and chromium may exist in solution as
anions, whereas most other carcinogenic metals
exist principally as cations.
A major difficulty with metal carcinogens is that
no specific metal-nucleic acid interactions analogous
tothose obtainedwith organicchemicalcarcinogens
and particular loci in DNA molecules have been
observed in vivo. Although recent evidence sug-
gests that most metals do not induce repairsynthe-
sis, studies using bacterial or eucaryotic mutants
deficient in DNA repair pathways should provide
valuable information on metal induced alterations
and mechanisms of repair. Furthermore, these
cellular assays provide an experimental setting for
tracing the involvement of mutations in carcino-
genesis. Inaddition, cell-free systems havepermitted
measurements of the effects of metals on the
fidelity ofDNA synthesis with the ultimate goal of
analyzing in molecular terms the mechanism of
metal carcinogenesis. Conversely, an understand-
ing of metal-cellular interactions should provide
newsystemstomoreadequatelyevaluatethetoxic,
mutagenic and carcinogenic effects of metals com-
monin ourenvironment. In view ofthese difficulties
and future prospects, recommendations are made
in this report and in the commissioned papers to
provide more infornation which will lead to an
understanding ofthe mechanisms ofmetal carcino-
genesis.
Bacterial Mutagenesis
Summary of Present Knowledge
To date, bacterial mutagenesis systems have not
been successful in predicting the carcinogenicity of
35metals. The strongest mutagenic effects in bacterial
systems are found with certain square planar
platinum compounds, e.g., cis-dichlorodiammine
platinum (II) (2, 3). There is also evidence for the
mutagenicityofchromium, selenium, andmanganese
compounds (4). Reports of positive results with
other metal compounds are incomplete or have not
been reproduced. Thus, as they are commonly
used, bacterial mutagenesis systems arenotadequate
forscreening metals but may be usefulfor studying
the mutagenic mechanisms of those metals which
give positive responses.
Chromate mutagenesis can be most easily detected
by the fluctuation test (5, 6), in which multiple
rounds of cell divisions occur in the presence of
nontoxic metal concentrations. A reasonable
hypothesis is that chromate mutagenesis occurs via
a decrease in the fidelity of DNA replication. If
other metal compounds act through similar
mechanisms, mutageniceffectsmightalsobedetected
by the fluctuation test. However, arsenite and
nickel were negative in this assay (5-7).
Bacterial mutagenesis assays may be useful in
screeningforcomutageniceffectsofmetalcompounds.
Since many metal ions have been shown to act as
enzyme inhibitors, enzymes involved in DNA repair
may be particularly susceptible to certain metal
compounds at subtoxic doses. These compounds
may act as comutagens by inhibiting repair of
DNA. Arsenic has been shown to inhibit DNA
repair in E. coli (8) and to enhance mutagenesis by
ultraviolet light (T. Rossman, unpublished obser-
vation). In performing such studies, a variety of
mutagenic agents requiring different modes of
DNArepair should be employed. The availability of
bacterial mutants defective in a variety of DNA
repair pathways make this system useful for
pinpointing mechanisms ofmutagenesis or comuta-
genesis (9). The use of selective toxicity on repair-
deficient mutants as a screen for DNA damaging
agents may prove valid for metals if it can be
demonstrated that (a) exposure to metal compounds
does in fact result in repairable damage to DNA;
and (b) the mutation in the repair-deficient strain
has no pleiotrophic effects which would result in
reduced viability under general stress. Another
bacterial assay system which might be useful in
studyingthemechanism ofaction ofmetalcompounds
is the induction of lambda prophage (10). Most
agents which damage DNA cause the induction of
prophage to the active viral form, resulting in viral
replication and lysis of the host cell. Mutagens
which interact with DNA polymerase to cause
decreased fidelity would not be expected to induce
prophage, whereas agents which cause base damage
of DNA strand breaks would act as prophage
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inducers. This system might be particularly useful
in cases where free radicals and peroxides are
generated.
Mammalian Cell Mutagenesis
Much more needs to be known about metal
mutagenesis in mammalian cells. The use of mam-
malian cells in metal mutagenesis studies will yield
important information with regard to insoluble
particulates whichmightnotpenetrate bacteriabut
couldpossiblyentermammaliancellsbypinocytosis,
and then be converted to an active species. In
addition, as in the case with bacterial systems,
comutagenesis assays could also be carried out in
mammalian cells.
Chinese hamster lines (11) (CHO and V79) and
the L5178y mouse lymphoma line are useful for
such studies (12). Available genetic loci include
Na-K ATPase, HGPRT, and thymidine kinase. In
addition, in order to facilitate mechanistic studies,
reversion assays should be developed to distinguish
between base-pair substitutions and frameshift mu-
tations. As in the case for bacterial mutagenesis,
various metallic species can be used in both long
tern exposure to nontoxic concentrations (as in a
fluctuation test) as well as short term exposure to
higher doses. Significant increases in the absolute
number ofmutants overthe control is preferable to
derived values (mutants/survivors) in determining
whether a compound is a mutagen.
Because the primarytargets formetals and other
carcinogens are often epithelial cells, and because
epithelial cells may differ from fibroblasts as to the
uptake and metabolism ofmetal compounds, muta-
genesis systems using epithelial cells from various
organs are needed.
In Vitro Cell Transformation
Quantitative in vitro transformation assays for
the evaluation ofthe potential carcinogenic activity
of metals are available using mammalian cell cul-
tures. These assays involve (a) transformation of
hamster or mouse cells following exposure to metal
salts (13) or (b) enhancement of viral transforma-
tion of cells following treatment with chemicals
(14).
Direct Chemical Transformation
Induction of morphologic transformation by or-
ganic chemical carcinogens has been demonstrated
in a variety of mammalian cells (15) and by the
inorganic metal salts in Syrian hamster embryo
cells. A number ofother cell systems are currently
Environmental Health Perspectivesbeing used to screen for potential carcinogens and
to study the processes ofinitiation, expression and
promotion. The mouse cell lines Balb 3T3 and
C3H1OT½2 have not been extensively used with
metal carcinogens. The Syrian hamster embryo cell
assay is suitable to study cell transformation in-
duced by metal salts. These cells are diploid, retain
metabolic function when used either freshly pre-
pared or as frozen stocks, undergo progressive
eventsleadingto expression ofthe neoplastic state,
and have very low frequency ofspontaneous trans-
formation. Furthermore, tumorigenicity isobserved
following the injection of these transformed cells
into random-bred newborn or weanling Syrian
hamsters. Assays are conducted by scoring
transformed colonies among surviving colonies or
as foci against a confluent background of normal
cells.
Metaplasia, hyperplasia and other phenomena
which are tissue specific mayplayan important role
in metal carcinogenesis. In addition, transforma-
tion assays should be attempted in epithelial sys-
tems (16), such as those now being developed for
skin (17) and liver cells (18). The possible use of
organfragments, inwhich histologic organization is
preserved, could also be explored.
Viral-Chemical Interactions
A sensitive assay for the demonstration of
carcinogenic potential of metal compounds is the
enhancement of SA7 virus-induced transformation
of hamster embryo cells. This test implies that
agents capable ofcausing direct or indirect damage
to cellular DNA will increase the frequency of
morphological transformation by increasing the
integration of viral DNA into cellular DNA at the
damage site. The assay has responded to a wide
variety of chemicals including known carcinogenic
metal compounds (14). The assay may be used to
obtain useful information regarding cooperative
actionbetweenmetals (synergistic orcocarcinogenic
activity); inhibition ofactivity by othermetals; and,
effective exposure time required for optimal bio-
logic activity. The temporal relationship between
metal and virus addition provides an indication of
the persistence of DNA damage induced by metal
treatment, e.g., rapid disappearance of enhancing
activity may be indicative of repair of damage,
whereas persistence ofenhancement indicates that
the damage remains. The sequence of addition of
virus and chemical in enhancement assays may also
provide some information concerning the mecha-
nism of action of metal carcinogens. Carcinogens
found to interact directly with cellular DNA will
increase the viral transformation frequency when
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added before orimmediately after DNA-virus inoc-
ulation; some carcinogens that do not appear to
directly damage or bind to DNA are found to be
more active when added 5-7 hr after virus addition
and cell transfer. The latter observation suggests
that enhancement may occur as a result ofinterfer-
ence with scheduled cell DNA synthesis during the
time thatviral DNA is beingprocessed into cellular
DNA, the interference may allow a greater oppor-
tunity for viral DNA to be integrated.
Cell-Free Systems
Cell-free bioassays may be developed as screen-
ing systems for indication of metal mutagens/
carcinogens (19, 20). This has been demonstrated
by the observations of Sirover and Loeb (20, 21)
and others (22) that mutagenic/carcinogenic metals
decrease the fidelity of in vitro DNA synthesis or
synthetic polynucleotide templates. These studies
have been further supported in experiments using
DNA polymerases from a variety of sources, and
most recently by the development of a bioassay
system which measures the fidelity by which a
natural template (from bacteriophage 4X174) is
copied in vitro (23).
Perhaps a more important aspect of cell-free
bioassays is the possibility ofexamining some ofthe
putative mechanisms ofmetalmutagenesis/carcino-
genesis. In cell-free systems, homogeneous reac-
tion components and conditions are defined and
thus can be systematically varied. For example,
DNA replication can be examined in the absence of
DNA repair, and the contribution of each of the
proteins involved in these processes can be deter-
mined. Furthermore, using such systems, one may
begin to analyze the effects of metals at the
molecular level. Metal ions may alter the fidelity of
DNA synthesis by interacting with nucleotide sub-
strates, the DNA polymerase, or with the DNA
template. An analysis ofthe changes in the nucleo-
tide sequence ofDNA products copied from natural
DNA templates in the presence of various metal
ions and/or biased nucleotide pools should provide
more definitive results concerning specificity of
metal-nucleotide and metal-template interactions.
Studies with E. coli and bacteriophage T4 indicate
that DNA replication proceeds by the concerted
action ofmultiple proteins. Using the 4X174 assay
system, it has been possible to measure the
contribution ofvariousreplicationproteinstofidelity
(24). Thus, the effects ofmetals on the accuracy of
DNA replication can be assayed in a cell-free
system that begins to approach the complexity
involved in chromosomal DNA replication in cells.
The aforementioned studies are based on the
37hypothesis that the mutagenic/carcinogenic effects
of metals result in the permanent alteration ofthe
DNA during DNA replication (somatic mutation
hypothesis). Alteration in reactants could be in
template, substrate, or enzyme. An alternative
mechanismofmetalmutagenesis/carcinogenesis may
involve the alteration ofgene expression, whichcan
also be examined in cell-free systems. One study
(25) indicates that chaininitiation ofRNAsynthesis
was stimulated by certain mutagenic metals and
was inhibited by several nonmutagenic metals.
Limited studies (25) have suggested thatmetalions
may also cause errors in RNA synthesis. These
phenomena, like metal induced infidelity of DNA
synthesis, could be a result of metal interactions
with the DNA template. Regulation of gene ex-
pression could also occur at the level ofthe cellular
proteins, and aspects of this may be examined in
cell-free systems. For example, a study (26) on the
fidelity of cell-free protein synthesis demonstrated
that high Mg concentrations increased the incorpo-
ration of incorrect amino acids into protein.
Anothermethod ofinterest is the affect ofmetals
on mixing curves of synthetic polyribonucleotides
(27). Manganese and cadmium induced mispairing,
whereas magnesium and zinc did not.
Chromosome Aberration, Sister-
Chromatide Exchange and
Micronucleus Tests
Themetaphase chromosomeaberrationsproduced
by metals represent one ofthe few practical meth-
ods currently available for evaluating prior genetic
damage in man. The induction of chromosome
aberrationsbymetalcompounds hasbeenextensively
studied in cultured mammalian cells (4, 19, 28).
There is a weak correlation between the frequency
ofchromosome aberrations and the carcinogenicity
ofmetal compounds. The majorproblem appears to
be the number offalse positive results obtained in
studies in cultured cells. This may occur because
the assay has not been optimized for the detection
of carcinogenic metals or because the observed
chromosome aberrations are not directly related to
carcinogenesis.
Two additional assays, sister-chromatid exchange
(SCE) (28-32) and micronucleus (extranuclear
interphase chromosome fragments) (33-35), are
increasingly being used in cytogenetic studies in
man and in experimental systems. Their potential
advantages over chromosome aberrations are eas-
ier enumeration and frequent detection at lower
doses of carcinogen. However, there are few pub-
lished dataontheproduction ofSCEsormicronuclei
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by metal compounds (36, 37). Their significance as
indicators ofgenetic damage is also not established.
Allthree assaysrequirevalidation and optimization
for the specific detection of metal carcinogens/
mutagens. For studies in vitro, the major parame-
ters to be examined are: treatment time (acute and
chronic), sample time, cell type (lymphocytes, cell
lines, primarycultures), specificity(whethercytogenic
damage is seen at nontoxic doses or only near the
toxic limit), treatment medium (buffers, culture
fluid, serum), and role ofchelatingagents. Allthree
assays could be performed in the same cell popula-
tion. This will allow a direct comparison of the
strengths and weaknesses of each assay and may
indicate suitable combinations to be used in routine
analysis.
The assays also require validation invivo. Again,
treatment time, sample time, and a variety of cell
types, e.g., lymphocytes, bone marrow cells, germ
cells, shouldbe sampled and examined. Comparison
of experimental results obtained in vitro may help
to determine the significance ofpositive and nega-
tive results in human studies.
Studies on the Mechanism of
Chromium Carcinogenesis
We have selected chromium as an example of a
metal in which detailed investigations of mecha-
nisms may yield results relevant to carcinogenesis.
Animal cancer studies implicate Cr(VI) as the
biologically active species in carcinogenesis. This
parallels the behavior in in vitro tests (e.g.,
mutagenicity in the Ames Salmonella assay), while
Cr(III) compounds prove more active in cell-free
bioassays ofgenetic toxicity (38, 39). These results
are explicable in terms of the uptake-reduction
model of Jennette (40). According to the model:
chromium enters the cell as the hexavalent species,
perhaps using the sulfate transport system (41).
Once inside thecell, microsomalenzymes, including
those ofthe P450 system, reduce hexavalent chro-
mium to trivalent chromium, which then reacts
with critical intracellular sites to induce genotoxic
effects. Recent data further suggest that reduced
chromium maybind directly to the nucleotide bases
in DNA (41). Thus, in the case of chromium,
evidence from in vitro tests consistently suggest
that carcinogenesis may involve mutagenic initia-
tion of somatic cells via direct DNA interactions.
The hypothesis that chromium is a mutagenic
initiator may now be explored by a variety of
procedures to further elucidate the biochemical
mechanisms involved in its carcinogenicity. This
could lead to an understanding of how one metal
Environmental Health Perspectivesacts as a carcinogen and would facilitate compara-
ble studies on other metals.
Role of Free Radicals in Metal
Carcinogenesis
There is considerable evidence that free radicals
generated by ionizing radiation or organic chemi-
cals play a role in carcinogenesis (42, 43). Many
transition metals, acting either as metal-enzymes
or in a complexed form, catalyze the oxidation of
endogenous or exogenous chemicals to produce
peroxides, epoxides, and free radicals such as
superoxide and hydroxyl (44). Many of these spe-
cies damage and inactivate DNA (45, 46), are
mutagenic (47-49), and may be carcinogenic (44,
50). The involvement of free radicals in metal
carcinogenesis/mutagenesis, therefore, deservesfur-
therinvestigation. These studies should be conducted
at the molecular and cellular levels.
Integration of In Vitro Bioassays
into Epidemiological Cancer
Studies
Present State of Knowledge
In order to validate the use of in vitro tests as
predictive indicators of carcinogenesis, the test
results must be integrated into epidemiological
cancer studies. Interdisciplinary investigations of
this nature are now in progress (51). Such studies
attempttoidentifythesignificant factorscontributing
to excess cancer rates in both occupational and
community-wide settings. Environmental and
biological samples are analyzed using in vitro
assays and chemical methods. These measurements
willprovide baselineinfonration forboth prospective
and retrospective epidemiological studies designed
to evaluate the contribution of metals and other
environmental factors in the etiology of cancer.
General Conclusion and
Recommendations
The in vitro assays provide excellent model
systems for the study ofmetal carcinogenesis. The
various areas amenable to research include: (a)
molecular analysis of mechanisms of metal muta-
genesis at the level ofDNA replication and repair;
(b) determination ofthose agents that may require
promotion for carcinogenic activity; (c) synergistic
actionbetween metals, includingsyncarcinogenesis
August 1981
and cocarcinogenesis; (d) antagonistic activity be-
tween metals; (e) prerequisite exposure periods for
demonstration ofbiologic activity; (f) assay ofgene
products in the same cells treated with various
metal salts.
Recommendations for
Future Research
Bacterial Mutagenesis
The fluctuation test should be used in testing
metals and their compounds formutagenesis. Toxic
doses should be used for short time periods and
dose- dependent increases in the absolute number
of mutants per plate should be observed before a
compound is reported to be a mutagen.
Strains of bacteria defective in mismatch repair
(52, 53) should be evaluated as possible indicator
stralns for metal mutagens, since this repair system
may eliminate errors in DNA replicated in the
presence of metal.
The ability of metals and their compounds to
induce lambda prophage should be tested. This
would be useful in studies on the mechanism of
metal mutagenicity and carcinogenicity.
Mammalian Cell Mutagenesis
A number of mammalian cell lines and genetic
markers should be used to assay for mutagenicity
by metal compounds. Chinese hamster (CHO, V79)
and mouse lymphoma (L51758y) cell lines, with
available genetic loci (Na, K-ATPase, HGPRT, and
thymidine kinase), are recommended.
Mutagenesis systems using epithelial cells from
various organs should be developed.
Cell Transformation
In vitro transformation by metal compounds
should be studied with the established Syrian
hamsterand mouse (Balb3T3, C3H1OT1/2) celllines,
and with epithelial cells (e.g., skin, liver) being
developed for such studies.
The enhancement of virus-induced transforma-
tion of hamster embryo cells by metal compounds
should be further explored to provide information
on metal-virus-gene interactions.
Cell-Free Systems
Furtherexploration ofmetal decreased fidelityof
DNA synthesis would be valuable in screening for
39metal carcinogens and in determining mechanisms
of metal carcinogenesis/mutagenesis.
Studies with a natural template (from bacterio-
phage 4)X174), in addition to synthetic polynucleo-
tides, would be especially useful in analyzing the
effects at the molecular level.
Additional studies on RNA and protein synthesis
would provide further information on the effects of
metals on gene expression.
Theeffects ofmetalsonmixingcurvesofsynthetic
polyribonucleotides should be studied.
Chromosome Aberrations
Increasedfrequenciesofchromosomeabnornalities
are suggestive, but not proof, of an increased risk
of cancer. Studies of chromosome abnormalities in
persons exposedtoknownorsuspected carcinogens,
properly controlled for age and characterized for
identity, level and duration ofexposure, can prove
useful for both research and public health purposes
(19, 28).
The finding of increased levels of chromosome
aberrations or SCEs in a group ofexposed persons
(in the absence of confounding factors such as
smoking) is cause to suggest: reduction-in exposure
to suspected agents, characterization of suspected
agents, and surveillance of the exposed group for
chromosomeabnormalities, morbidityandmortality.
Chromosomalaberrations, SCE, andmicronucleus
formations should be measured in animals involved
in carcinogenicity bioassays.
Assay for nondisjunction should be developed in
man. Nondisjunction generates aneuploidy in man
but cannot be determined by standard cytogenetic
techniques. New techniques, such as variation in
DNA content of sperm are promising, but require
validation.
Criteriaforacceptableresultsshouldbedetermined
in assays. Minimal standards for acceptability are:
enumerationoftypesofaberrations, multiplesample
times, scoring of at least 100 metaphases for
chromosome aberrations, or 30 metaphases for
SCE.
Mechanism of Chromium Carcinogenesis
Chromium metabolism in bacteria and animal
cells in culture should be studied.
Effects of organochromium complexes, both in
vitro and in whole animal bioassays, should be
analyzed.
The mechanism of chromium mutagenesis and
oncogenic transformation of animal cells. in culture
should be investigated.
The initiating and promoting activity in skin
tumor sensitive (Sencar) mice (54) and in cells in
vitro (55) should be determined.
The distribution and binding of chromium to
cellular organelles and macromolecules should be
studied.
Chromium effects on the cell-free synthesis of
DNA, RNA and protein, with particular emphasis
on fidelity, should be analyzed.
Cr(III)-DNA adducts and damage to DNAcaused
by Cr should be characterized.
Role of Free Radicals
The presence of free radicals in metal treated
cells and cell-free systems should be determined by
electron spin resonance spectroscopy using spin
traps (56).
The effects offree radicals should be determined
byinhibition ofmetal mediated events usingcatalase,
superoxide dismutase, and free radical scavengers.
Integration of In Vitro Bioassays into
Epidemiological Cancer Studies
Integrationofinvitrobioassaysintoepidemiological
studies of metal carcinogenesis can provide useful
comparisons. Such studies could be carried out
among workers occupationally exposed to metal
carcinogens. Welders, for example, are exposed to
carcinogenic chromium compounds in the stainless
steel fumes generated during arc welding operations.
Epidemiological and cytogenetic studies of groups
ofexposed-persons could beintegrated with studies
ofsamples collected fromthe workplace. In addition
tophysicalandchemicalanalysis, workplacesamples
could alao be analyzed for mutagenic activity using
in vitro tests.
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